Indeed exciting lineup! Appreciate this list. Also - don't miss Capitello 291 PFS2 demonstrating continued efficacy of capi/fulv vs fulv through subsequent lines of Rx. OncoAlert ESMO - Eur. Oncology #ESMOBreast24